IP Library › Granted Patent US 11,484,320
Granted Patent B2
US 11,484,320 · App. 17/125,747 · Granted Nov 1, 2022

Left atrial appendage closure device with anti-thrombogenic covering

Inventors: Steven L. Kangas (Woodbury, MN); Edward Kopesky (Mahtomedi, MN); Yen-Lane Chen (New Brighton, MN)
Assignee: Boston Scientific Scimed, Inc.
A61B17/12122A61B17/12031A61B17/12172A61B17/12177A61L33/0005A61L2430/36
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,484,320
App. No.
17/125,747
Granted
Nov 1, 2022
Kind
B2
Abstract

Medical devices as wells as methods for making and using medical devices are disclosed. An example medical device may include a left atrial appendage device. The left atrial appendage device may include an expandable frame configured to shift between a first configuration and an expanded configuration. A fabric mesh may be disposed along at least a portion of the expandable frame. An anti-thrombogenic coating may be disposed along the fabric mesh.

Claims (23)

1. A left atrial appendage device, comprising:

an expandable frame configured to shift between a first configuration and an expanded configuration;

a fabric mesh disposed along at least a portion of the expandable frame;

an anti-thrombogenic coating disposed along the fabric mesh;

wherein the fabric mesh includes a plurality of filaments;

wherein the plurality of filaments are arranged into a fiber bundle; and

wherein the anti-thrombogenic coating migrates to an interior region of the fiber bundle.

2. The left atrial appendage device of claim 1 , wherein the plurality of filaments include polyethylene terephthalate.

3. The left atrial appendage device of claim 1 , wherein the plurality of filaments include polyester.

4. The left atrial appendage device of claim 1 , wherein the anti-thrombogenic coating encapsulates at least some of the plurality of filaments.

5. The left atrial appendage device of claim 1 , wherein the anti-thrombogenic coating individually coats each of the plurality of filaments.

6. The left atrial appendage device of claim 1 , wherein the plurality of filaments are arranged in a non-woven configuration.

7. The left atrial appendage device of claim 1 , wherein the anti-thrombogenic coating includes a fluoropolymer.

8. The left atrial appendage device of claim 1 , wherein the anti-thrombogenic coating includes polyvinylidene fluoride.

9. The left atrial appendage device of claim 1 , wherein the anti-thrombogenic coating includes a polyvinylidene fluoride copolymer.

10. The left atrial appendage device of claim 1 , wherein the anti-thrombogenic coating includes poly(vinylidene fluoride-co-hexafluoropropylene).

11. The left atrial appendage device of claim 1 , wherein the anti-thrombogenic coating includes poly[bis (trifluoroethoxy)phosphazene].

12. A left atrial appendage device, comprising: an expandable framework configured to shift between a delivery configuration and a deployed configuration; wherein the expandable framework is configured to engage a left atrial appendage when in the deployed configuration; a fabric disposed along at least a portion of the expandable framework, the fabric including one or more knitted fiber bundles; wherein each of the one or more knitted fiber bundles include a plurality of filaments; and an anti-thrombogenic coating disposed along each of the plurality of filaments that migrates to an interior region of the knitted fiber bundle.

13. The left atrial appendage device of claim 12 , wherein the anti-thrombogenic coating encapsulates each of the plurality of filaments.

14. The left atrial appendage device of claim 12 , wherein the anti-thrombogenic coating includes a fluoropolymer.

15. The left atrial appendage device of claim 12 , wherein the anti-thrombogenic coating includes poly(vinylidene fluoride-co-hexafluoropropylene).

16. An occlusive medical device, comprising: an expandable frame configured to shift between a delivery configuration and an expanded configuration; wherein the expandable frame is configured to be implanted adjacent to a left atrial appendage; a fabric mesh disposed along at least a portion of the expandable frame, the fabric mesh including one or more fiber bundles arranged into a pattern; wherein each of the one or more fiber bundles include a plurality of filaments; an anti-thrombogenic coating disposed along each of the plurality of filaments that migrates to an interior region of the one or more fiber bundles; and wherein at least one of the one or more fiber bundles includes an interior region and wherein a section of the anti-thrombogenic coating is disposed along the interior region.

17. The occlusive medical device of claim 16 , wherein the anti-thrombogenic coating encapsulates each of the plurality of filaments.

Continuity (2)
Provisional Application 62949976 · Dec 18, 2019
Related Publication 20210186516A1 · Jun 24, 2021
Cited By (4)
US 12,256,938 US 12,268,394 US 12,376,861 US 12,714,432